Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 69097-741

4 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 69097-741). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Emtricitabine-structure (Emtricitabine Structure)

Emtricitabine-structure (Emtricitabine Structure)
Chemical structure of emtricitabine, one of the active ingredients in the product EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE. The diagram shows the molecular components and bonds of emtricitabine.*
FDA Label Image

Tdf-structure (Tdf Structure)

Tdf-structure (Tdf Structure)
Chemical structure diagram of emtricitabine and tenofovir disoproxil fumarate, the active ingredients in the drug EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE.*
FDA Label Image

Emtri-tdf-tabs-ciplaptg (Emtri Tdf Tabs Ciplaptg)

Emtri-tdf-tabs-ciplaptg (Emtri Tdf Tabs Ciplaptg)
Label for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, film-coated, with strengths 200 mg/300 mg. The label shows the product name, dosage form, strength, and a count of 30 tablets. It includes the labeler Cipla USA Inc. and instructions for pharmacists to dispense the accompanying Medication Guide. There is space indicated for batch overprinting of serial number, expiry, and lot information. The label also features barcodes and manufacturing details.*
FDA Label Image

Emtri-tdf-tabs-appcocipla (Emtri Tdf Tabs Appcocipla)

Emtri-tdf-tabs-appcocipla (Emtri Tdf Tabs Appcocipla)
Label for Emtricitabine and Tenofovir Disoproxil Fumarate tablets, film-coated, oral dosage form, strength 200 mg/300 mg. The label includes active ingredient amounts, manufacturer Cipla USA Inc., and packaging details for 30 tablets with child-resistant packaging instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.